Impaired cerebral vasoreactivity in white coat hypertensive adolescents

European Journal of Neurology

Volumn 18, Issue 4, 2011, Pages 584-589

  Pall D ^a   Lengyel, S ^a   Komonyi, E ^a   Molnar C ^a   Paragh, G ^a   Fulesdi B ^a   Katona, E ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adolescent hypertension; Cerebral vasoreactivity; Transcranial Doppler sonography; White coat and sustained hypertension

Indexed keywords

CARBON DIOXIDE; NITRIC OXIDE;

ADOLESCENT; ARTERIOLE; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BREATH HOLDING; CEREBRAL VASOREACTIVITY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; SUSTAINED HYPERTENSION; WHITE COAT HYPERTENSION;

ADOLESCENT; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING, AMBULATORY; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HYPERTENSION; MALE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79952719839     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03209.x     Document Type: Article

References (33)

1. Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009; 27: 1719-1742.
2. Pàll D, Katona E, Fülesdi B, et al. Blood pressure distribution in a Hungarian adolescent population: comparison with normal values in the USA. J Hypertens 2003; 21: 41-47.
3. Sinaiko AR, Gomez-Marin O, Prineas RJ. Prevalence of "significant" hypertension in junior high school-aged children: the Children and Adolescent Blood Pressure Program. J Pediatr 1989; 114: 664-669.
4. Flynn JT. Hypertension in adolescents. Adolesc Med Clin 2005; 16: 11-29.
5. Flynn JT. Pediatric hypertension update. Curr Opin Nephrol Hypertens 2010; 19: 292-297.
6. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol 2005; 20: 961-966.
7. Puato M, Palatini P, Zanardo M, et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 2008; 51: 1300-1305.
8. Ficzere A, Valikovics A, Fülesdi B, Juhász A, Czuriga I, Csiba L. Cerebrovascular reactivity in hypertensive patients: a transcranial Doppler study. J Clin Ultrasound 1997; 25: 383-389.
9. Magyar MT, Valikovics A, Czuriga I, Csiba L. Changes of cerebral hemodynamics in hypertensives during physical exercise. J Neuroimaging 2005; 15: 64-69.
10. Settakis G, Páll D, Molnár C, Bereczki D, Csiba L, Fülesdi B. Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging 2003; 13: 106-112.
11. Settakis G, Páll D, Molnár C, Katona E, Bereczki D, Fülesdi B. Hyperventilation-induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res 2006; 29: 306-311.
12. Inoue N, Harada M. Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures. Arzneimittelforschung 2008; 58: 317-322.
13. Zanchetti A, Hennig M, Hollweck R, et al. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009; 120: 1084-1090.
14. Pauletto P, Palatini P, Da Ros S, et al. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999; 19: 1231-1237.
15. Lonati L, Cuspidi C, Sampieri L, et al. Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives. Cardiology 1993; 83: 298-303.
16. Cuspidi C, Lonati L, Sampieri L, Leonetti G, Zanchetti A. Similarities and differences in structural and functional changes of left ventricle and carotid arteries in young borderline hypertensives and in athletes. J Hypertens 1996; 14: 759-764.
17. Toikka JO, Laine H, Ahotupa M, et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000; 36: 929-933.
18. Femia R, Kozakova M, Nannipieri M, et al. Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression. Arterioscler Thromb Vasc Biol 2007; 27: 2244-2249.
19. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25: 1751-1762.
20. Naschitz JE, Loewenstein L, Lewis R, et al. Accuracy of the OMRON M4 automatic blood pressure measuring device. J Hum Hypertens 2000; 14: 423-427.
21. Stergiou GS, Karpettas N, Atkins N, O'Brien E. European society of hypertension international protocol for the validation of blood pressure monitors: a critical review of its application and rationale for revision. Blood Press Monit 2010; 15: 39-48.
22. Barna I, Keszei A, Dunai A. Evaluation of meditech ABPM-04 ambulatory blood pressure measuring device according to the British hypertension society protocol. Blood Press Monit 1998; 3: 363-368.
23. O'Brien E. State of the market in 2001 for blood pressure measuring devices. Blood Press Monit 2001; 6: 171-176.
24. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995-2007.
25. Settakis G, Lengyel A, Molnár C, Bereczki D, Csiba L, Fülesdi B. Transcranial Doppler study of the cerebral hemodynamic changes during breath-holding and hyperventilation tests. J Neuroimaging 2002; 12: 252-258.
26. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
27. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385-1392.
28. Verdecchia P, Angeli F, Gattobigio R, et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit 2007; 12: 387-389.
29. Spence JD. White-coat hypertension is hypertension. Hypertension 2008; 51: 1272.
30. Lavi S, Gaitini D, Milloul V, Jacob G. Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2006; 291: H1856-H1861.
31. Katona E, Settakis G, Varga Z, et al. Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1. J Neurol Sci 2006; 247: 138-143.
32. Birns J, Jarosz J, Markus HS, Kalra L. Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiatry 2009; 80: 1093-1098.
33. Katona E, Settakis G, Varga Z, et al. Both nitric oxide and endothelin-1 influence cerebral blood flow velocity at rest and after hyper- and hypocapnic stimuli in hypertensive and healthy adolescents. Kidney Blood Press Res 2006; 29: 152-158.